Therefore, and given the strong correlation of the mesenchymal transition signature with CD44, one possible explanation for the absence of the mesenchymal transition signature in patients with exceptionally long time to recurrence may be due to a corresponding lack of stemness in the cancer cells of these patients making it more unlikely for the cancer to recur following treatment. Here, CD44 is linked to cancer.